Results 81 to 90 of about 9,251 (162)

Biochemical and Pharmacological Analyses of HIV-1 Integrase Flexible Loop Mutants Resistant to Raltegravir [PDF]

open access: green, 2010
Mathieu Métifiot   +5 more
openalex   +1 more source

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) [PDF]

open access: gold, 2010
Joseph J. Eron   +12 more
openalex   +1 more source

Resistance to inhibitors of the human immunodeficiency virus type 1 integration

open access: yesBrazilian Journal of Infectious Diseases, 2010
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection.
Daria J. Hazuda, PhD
doaj  

Etravirine–raltegravir, a marked interaction in HIV-1-infected patients: about four cases

open access: bronze, 2009
Amélie Menard   +7 more
openalex   +1 more source

Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy [PDF]

open access: green, 2010
Deborah McMahon   +12 more
openalex   +1 more source

Prevention of HIV Protease Inhibitor-Induced Dysregulation of Hepatic Lipid Metabolism by Raltegravir via Endoplasmic Reticulum Stress Signaling Pathways [PDF]

open access: green, 2010
Risheng Cao   +10 more
openalex   +1 more source

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV‐1‐infected patients with undetectable viremia [PDF]

open access: gold, 2010
Carmen Garrido   +6 more
openalex   +1 more source

Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection

open access: bronze, 2009
Martin Markowitz   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy